Biotech

All Articles

Lilly- backed weight reduction biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis usage medication fails stage 2b, driving Indivior to reassess $100M choice

.Aelis Farma's chances of securing a simple, beneficial decision on a $100 thousand possibility repa...

ProKidney standstills period 3 test certainly not needed to have for cell therapy approval

.ProKidney has actually stopped some of a pair of stage 3 trials for its cell treatment for kidney i...

Vaxcyte climbs on 'impressive' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what experts called "impressive" period 1/2 records for its own 31-valent pneumoco...

Recursion's brain health condition trial reveals scant documentation of effectiveness

.Recursion has discovered via an early exam of its tech-enabled approach to medicine exploration, di...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Phone it a case of excellent chemistry: Acepodia, a biotech based on Nobel Champion scientific rese...

Praxis epilepsy drug lessens confiscations in period 2 hearing

.Praxis Preciseness Medicines has racked up one more midphase gain in epilepsy this year, with its s...

Three officers surrender as Dyne posts blended information for DMD prospect

.After getting away from a scientific hold a number of years back, Dyne Rehab has uncovered brand ne...

Arrowhead fires off stage 3 data in unusual metabolic condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own hand in advance of a possible face-off along with I...

Pfizer, Valneva reveal lyme health condition try helpful for 2nd booster

.Pfizer as well as Valneva might have concerning 2 more years to wait prior to they create the initi...